Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × veliparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1

Interventions

pegaspargase 4 tislelizumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Etoposide 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 sugemalimab 1 selinexor 1 relatlimab 1 pembrolizumab 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Methylprednisolone 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡